RARA CRAFT DATABASE for FDA Medical Devices
510(k)K190147

FDA DEVICE FACTS

COLOSSEUM Mesh

Globus Medical, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 8, 2019PRODUCT CODEMQP

Indications for use

When used as a vertebral body replacement device in the cervical spine (C2-T1), COLOSSEUM™ Mesh devices are intended for use in skeletally mature patients to replace a diseased or damaged vertebral body caused by tumor, f racture, or osteomyelitis, or for reconstruction following corpectomy perfo rmed to achieve decompression of the spinal cord and neural tissues in cervical degenerative disorders. These spacers are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in pati ents with advanced stage tumors involving the cervical spine in whom life expectan cy is of insufficient duration to permit achievement of fusion, with bone graft used a t t h e s u r g e o n ’ s discretion. When used as a vertebral body replacement device in the thoracolumbar spine (T1- L5), COLOSSEUM™ Mesh devices are intended for use to replace a collapsed, damaged, or unstable vertebral body due to tumor or trauma (i.e ., fracture). These spacers are designed to provide anterior spinal column support even in the absence of fusion for a prolonged period. The interior of the vertebral body replacement device spacers ca n be packed with autograft or allogenic bone graft comprising cancellous and/or corticocancellous bone graft as an adjunct to fusion. These devices are intended to be used with FDA-cleared supplemental spinal fixation systems that have been lab eled for use in the cervical, thoracic, and/or lumbar spine (i.e., posterior screw and rod systems, anterior plate systems, and anterior screw and rod systems). Wh en used at more than two levels, supplemental fixation should include posterior fixation.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 25, 2026